SLC2A1 and neoplasm: For instance, Lippard et al. have provided a robust proof‐of‐concept by demonstrating that three rationally designed platinum(II)‐glycoconjugates exhibit pronounced antiproliferative effects across a panel of human tumor cell lines via GLUT‐mediated transport pathways, resulting in preferential intracellular accumulation within cancer cells in vitro, thereby providing solid validation of the proposed targeting strategy.[27,28]